End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 37 | 21-04-11 | |
Devin J. Shaw
DFI | Director of Finance/CFO | 37 | 21-04-12 |
John Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 17-12-10 |
Tony Fiorino
BRD | Director/Board Member | 56 | 17-08-14 |
Boris Shor
PRN | Corporate Officer/Principal | - | - |
John P. Clark
AUD | Comptroller/Controller/Auditor | 52 | 17-11-19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | - |
Tony Fiorino
BRD | Director/Board Member | 56 | 17-08-14 |
John A. Neczesny
BRD | Director/Board Member | 60 | 16-02-01 |
Daniel Kazado
BRD | Director/Board Member | 59 | 13-10-09 |
Jeff Paley
BRD | Director/Board Member | 55 | 16-02-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 3,713 | 0 | 0 | 100.00 % |
Stock B | 1 | 172,878,093 | 172,878,093 ( 100.00 %) | 0 |
Company contact information
Immune Pharmaceuticals, Inc.
1 Bridge Plaza North Suite 270
07024, Englewood Cliffs
+201-464-2677
http://www.immunepharma.comSector
1st Jan change | Capi. | |
---|---|---|
+61.53% | 856B | |
+38.95% | 631B | |
-3.66% | 359B | |
+15.06% | 325B | |
+9.18% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+15.67% | 177B | |
+2.47% | 165B |
- Stock Market
- Equities
- FZRQ Stock
- Stock
- Company Immune Pharmaceuticals Inc